ahc 52 has been researched along with nicardipine in 2 studies
| Studies (ahc 52) | Trials (ahc 52) | Recent Studies (post-2010) (ahc 52) | Studies (nicardipine) | Trials (nicardipine) | Recent Studies (post-2010) (nicardipine) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 2,646 | 444 | 312 |
| Protein | Taxonomy | ahc 52 (IC50) | nicardipine (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 8.314 | |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 8 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 4.2992 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.42 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 1.69 | |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 2.5 | |
| Cytochrome P450 2J2 | Homo sapiens (human) | 1.69 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 4.925 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 4.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, Y; Watanabe, N; Yamashiro, T | 1 |
| Kobayashi, Y; Koga, C; Tsuruo, T; Watanabe, N; Yamashiro, T; Yokoyama, KK | 1 |
2 other study(ies) available for ahc 52 and nicardipine
| Article | Year |
|---|---|
Reduction of intracellular pH by inhibitors of natural killer cell activity, nicardipine, methyl 2-(N-benzyl-N-methylamino)ethyl-2,6-dimethyl-4-(2-isopropyl-pyrazolo[1, 5-a]pyridine-3-yl)-1,4-dihydro-pyridine-3,5-dicarboxylate (AHC-52), and 4,4'-diisothio
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytotoxicity, Immunologic; Dihydropyridines; Flow Cytometry; Humans; Hydrogen-Ion Concentration; Killer Cells, Natural; Nicardipine; Pyrazoles; Tumor Cells, Cultured | 1997 |
Requirement of expression of P-glycoprotein on human natural killer leukemia cells for cell-mediated cytotoxicity.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Cell Survival; Cytotoxicity, Immunologic; Dihydropyridines; Drug Resistance, Multiple; Humans; Killer Cells, Natural; Nicardipine; Oligonucleotides, Antisense; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrazoles; RNA, Messenger; Thymoma; Thymus Neoplasms; Transcription, Genetic; Tumor Cells, Cultured | 1998 |